SWM
HARP

Spire Wealth Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Spire Wealth Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$2K – 2700
2022
Q2 		$2K Buy
+100
New +$2.59K ﹤0.01% 2428

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return

Spire Wealth Management's HARP Position: Q3 2022 in Review

Spire Wealth Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2022, closing a stake of 100 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in HARP in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 52 funds tracked by Wall St. Rank hold HARP as of Q3 2022.

  • Spire Wealth Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Spire Wealth Management sold 100 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Spire Wealth Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Spire Wealth Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.